Preparation for a U.S. Customs & Border Protection Audit
01:00 PM ET | 10:00 AM PT | 12:00 PM CT Duration 90 Minutes
Webinar Includes : All the training handouts , certificate ,Q/A and 90 mins Live Webinar
"Hear By Jan Seal is a Management Consultant on International Trade and a Licensed Customhouse Broker with over 40 years of experience in imports and exports"
Learn how to take "reasonable care"
A focused assessment (U.S. import audit) is conducted by CBP's Regulatory Audit Division to evaluate an importer's risk of non-compliance with import requirements and evaluation of internal controls. Non-compliance with import requirements and regulations can lead to additional duties, fees, and penalties.
Why Should You Attend:
Learn what is required by U.S. Customs & Border Protection (CBP) when they conduct a focused assessment (import audit) in your company. This webinar will assist you in identifying potential risk factors in the area of import compliance that could subject you to severe penalties and delays in clearing goods through CBP. It will also provide recommendations for some best practices that may resolve non-compliant import procedures and documentation or improve existing procedures. These best practices can increase your chances of receiving acceptable compliance rates under the focused assessment program. It may also reduce the time that auditors will need to spend in your company. Learn how to take "reasonable care" and create an import compliance manual.
• Customs Modernization Act
• Reasonable Care and Informed Compliance
• Role of Customs Auditors, Import Specialists, Investigators.
• Focused Assessment Requirements
• Importer Self-Assessment (ISA) Program
• Recordkeeping Requirement
• Standard Operating Procedures for U.S. Imports
• Best Practices
Who will Benefit
Importers, Departments such as:
• Import Compliance
• Engineering; and Freight Forwarders/Customhouse Brokers
• In-house Attorneys
Industries who can attend
his 90-minute online course is intended for professionals in the Import and export Industry. Although not presently stated in the draft , the same guide could be used by FDA Regulated Industries personnel